FDA to Decide on Bluebird Bio’s Gene Therapy for Sickle Cell Disease
Bluebird Bio's gene therapy for Sickle Cell Disease (SCD), lovotibeglogene autotemcel (lovo-cel), is awaiting FDA approval, with the decision expected [...]
Federal Appeals Court Restricts Access to Abortion Pill Mifepristone
A federal appeals court has ruled to restrict access to the abortion pill mifepristone but has not removed it from [...]
Updates to Keep an Eye on
The FDA has fast-tracked approval of Pfizer's Elfrexfio drug for hard-to-treat multiple myeloma, offering new hope to patients. State and [...]
Rising Biotech Stocks: Key Players to Monitor
10 Things You Need to Know: Biotech stocks continue to prosper long-term despite periodic fluctuations. In 2020, prominent biotech companies [...]
Biopharma Companies Plan of Attack After COVID-19 Revenue Boom
The COVID era created new mass-market drugs and vaccines requiring substantial investments. However, investors and analysts urge companies to adapt [...]
Supreme Court Halts Purdue Pharma’s Bankruptcy Plan Worth Billions
The Supreme Court has ordered a temporary halt on the proposed bankruptcy plan for Purdue Pharma, [...]
Skepticism Surrounds NIH’s Long Covid Clinical Trials
The National Institutes of Health (NIH) initiated clinical trials for long Covid – persistent symptoms following [...]
Act4Biosimilars Advocacy Group Strives to Boost Global Adoption of Biosimilars by 2030
Act4Biosimilars, a global biosimilar advocacy initiative, aims to increase global adoption of biosimilars by at least [...]
BioMarin’s Voxzogo Sales Forecast Rises Despite Supply Constraints
Voxzogo's success is posing challenges for BioMarin. Here's what you need to know: BioMarin's drug, Voxzogo, is performing better than [...]
AI’s Impact and Challenges in the Medical Device and Pharmaceutical Industries
AI and technologies such as computer vision are profoundly influencing the medical device and pharmaceutical industries by bolstering safety, efficiency, [...]
Sarepta Therapeutics Begins Dosing Duchenne Patients with Newly Approved Gene Therapy
Sarepta Therapeutics has started dosing Duchenne muscular dystrophy patients with its recently approved gene therapy, Elevidys, and plans to serve [...]
Cost and Accessibility Concerns Over Lecanemab
The first drug aiming to slow the progression of Alzheimer's, lecanemab (brand name Leqembi), could cost the U.S. health care [...]
Medicare Drug Price Negotiations Predicted to Yield $1.8 Billion Savings by 2026
A new report asserts that the Inflation Reduction Act will enforce a minimum discount that surpasses the 2020 rebates for [...]
GSK Sues Pfizer Over Alleged RSV Vaccine Patent Infringement
Pharmaceutical companies GSK and Pfizer are engaged in a legal dispute over supposed patent infringement. GSK alleges that Pfizer’s respiratory [...]
EQRx to be Acquired by Revolution Medicines
EQRx, a company with the intention of disrupting the pharma pricing system, has agreed to be taken over by Revolution [...]
Millennials and Gen Z More Likely to Buy from Brands Promoting Healthy Lifestyle
According to a DirecTV Advertising report, Millennials and Gen Z are more inclined towards brands promoting a healthy lifestyle than [...]
Infectious Disease Market Projected to Grow by 5.7% Led by Pfizer, Gilead Sciences, and GSK
According to a report by GlobalData, the infectious disease market is projected to grow actively from 2023 to 2029 and [...]
GSK Preps for Fall Launch of RSV Vaccine; CEO Expects Slower Initial Uptake
What You Need to Know: GSK has developed a vaccine against the respiratory syncytial virus (RSV) and is preparing to [...]
Biogen Plans Workforce Reduction and Refocuses on Lucrative Projects
Biogen has reported plans to cut 11.5% of its workforce, equating to about 1,000 employees, by 2025. This move forms [...]
Biopharma Companies Report Strong Earnings Amid Leadership Changes and Challenging Market Conditions
Quarterly earnings from large biopharma companies like Johnson & Johnson and Novartis kicked off last week, revealing positive sales growth [...]
FDA Approves Verrica Pharmaceuticals’ Ycanth
The U.S. Food and Drug Administration (FDA) approved Verrica Pharmaceuticals Inc.'s treatment Ycanth for a viral skin infection known as [...]
Medical Affairs Outsourcing Market Forecasted to Reach $3.28B by 2027
The global Medical Affairs Outsourcing Market is forecast to reach $3,287.12 million by 2027 from $1,415.00 million in 2019, growing [...]
Novo Nordisk Grapples with Supply Shortage Amid Surging Demand for Weight-Loss Drugs
Novo Nordisk is facing a supply shortage for its weight-loss drugs, Wegovy and Saxenda, due to surging demand… Here’s What [...]
ITIF Report: Global Drug Price Controls Restrict Pharmaceutical Research and Development
The Information Technology and Innovation Foundation (ITIF) study reports that drug price controls in non-US Organization for Economic Cooperation and [...]
BridgeBio’s Experimental Results Boosts Company Shares by 65%
BridgeBio Pharma Inc's experimental drug, acoramidis, for rare heart disease, has shown significant improvement in a late-stage study, boosting its [...]
